Mycoplasma pneumoniae – modern data on the structure, molecular biology and epidemiology of the pathogen

Mycoplasma pneumoniae – modern data on the structure, molecular biology and epidemiology of the pathogen

Mycoplasma pneumoniae is a common etiologic agent of respiratory tract infections and communityacquired pneumonia (CAP) in children and adults. Recently, much new data on this pathogen, its molecular biology, cytoadherence and epidemiology have been accumulated. This review describes in detail the f...

Full description

Bibliographic Details
Main Author:	Edelstein I.A.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2023-12-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	mycoplasma pneumoniae genome epidemiology pneumonia macrolide resistance
Online Access:	https://cmac-journal.ru/publication/2023/4/cmac-2023-t25-n4-p332/cmac-2023-t25-n4-p332.pdf

Similar Items

Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020–2022
by: Meng Xu, et al.
Published: (2024-01-01)

Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Southern Taiwan
by: Chih-Hao Chang, et al.
Published: (2021-09-01)

Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia
by: Abdul-Rahman Mamdouh Mohammad, et al.
Published: (2020-12-01)

Multilocus Sequence Typing of Mycoplasma pneumoniae, Japan, 2002–2016
by: Mariko Ando, et al.
Published: (2018-10-01)

The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019–2020
by: Cheng-Yen Kuo, et al.
Published: (2022-08-01)

Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020
by: Xue Wang, et al.
Published: (2022-12-01)

An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report
by: Munehiro Matsumoto, et al.
Published: (2019-02-01)

Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods
by: Ying Chen, et al.
Published: (2024-03-01)

Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
by: Fei Zhao, et al.
Published: (2020-10-01)

Cavitatory necrotising pneumonia with extrapulmonary multi-systemic involvement — a rare presentation of macrolide-resistant Mycoplasma pneumoniae
by: Namitha Mohan, et al.
Published: (2023-03-01)

Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
by: Diana Averbuch, et al.
Published: (2011-06-01)

New Insights into the Epidemiological Characteristics of <i>Mycoplasma pneumoniae</i> Infection before and after the COVID-19 Pandemic
by: Qianyue Wu, et al.
Published: (2024-10-01)

Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia
by: Roger Dumke, et al.
Published: (2014-12-01)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
by: Yu-Chin Chen, et al.
Published: (2020-07-01)

Four cases of resistance mutations in 23S rRNA gene in Mycoplasma pneumoniae isolated from the hospitalized military personnel
by: Edelstein I.A., et al.
Published: (2017-08-01)

Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011
by: AliReza Eshaghi, et al.
Published: (2013-09-01)

Neurological manifestations of Mycoplasma pneumoniae infection
by: A. Chakroun, et al.
Published: (2021-09-01)

The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children
by: Maodong Leng, et al.
Published: (2023-03-01)

New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis
by: Xiaoxiao Song, et al.
Published: (2024-10-01)

Effect of 23S rRNA gene mutations in Mycoplasma pneumoniae on severity of communityacquired pneumonia in young adult patients treated at the Smolensk militar y hospital
by: Ivanova O.V., et al.
Published: (2020-12-01)

Características clínicas y epidemiológicas de las neumonías adquiridas en la comunidad por Mycoplasma pneumoniae en una población española, 2010-2015
by: David Aguilera-Alonso, et al.
Published: (2019-07-01)

The Clinical Significance of Pathogen Loads and Macrolide Resistance Levels for Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children
by: Leng M, et al.
Published: (2024-10-01)

Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials
by: Hwan Soo Kim, et al.
Published: (2019-12-01)

Genotype and mutation patterns of macrolide resistance genes of Mycoplasma pneumoniae from children with pneumonia in Qingdao, China, in 2019
by: Fa-Chun Jiang, et al.
Published: (2021-12-01)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental <i>Mycoplasma pneumoniae</i> Pneumonia Unresponsive to Initial Macrolide Monotherapy
by: Eunha Bae, et al.
Published: (2022-09-01)

Macrolide-resistant <it>Mycoplasma pneumoniae</it> in adolescents with community-acquired pneumonia
by: Miyashita Naoyuki, et al.
Published: (2012-05-01)

FEATURES OF THE OUTBREAK OF THE COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY MYCOPLASMA PNEUMOINIAE AT CHILDREN IN KHABAROVSK REGION
by: O. E. Guseva, et al.
Published: (2018-02-01)

Macrolide-resistant mycoplasma pneumoniae infection in children observed during a period of high incidence in Henan, China
by: Maodong Leng, et al.
Published: (2024-07-01)

Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
by: Yuqian Zhang, et al.
Published: (2025-01-01)

Comparative characteristics of typical and atypical (Mycoplasma) pneumonia in children
by: T. A. Britkova, et al.
Published: (2021-07-01)

Clinical Manifestations, Macrolide Resistance, and Treatment Utilization Trends of <i>Mycoplasma pneumoniae</i> Pneumonia in Children and Adolescents in South Korea
by: Joon Kee Lee, et al.
Published: (2024-08-01)

Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea
by: Eun Lee, et al.
Published: (2020-02-01)

Impact of the COVID-19 pandemic on epidemiological and clinical characteristics of Mycoplasma pneumoniae pneumonia in children: a multicenter study from Hubei, China
by: Hui Du, et al.
Published: (2024-10-01)

Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis
by: Jong Gyun Ahn, et al.
Published: (2021-09-01)

Update on the Epidemiology of Macrolide-Resistant <i>Mycoplasma pneumoniae</i> in Europe: A Systematic Review
by: Daniela Loconsole, et al.
Published: (2021-09-01)

Increased macrolide resistance rate of Mycoplasma pneumoniae correlated with epidemic in Beijing, China in 2023
by: Yujie Chen, et al.
Published: (2024-08-01)

Novel mechanisms of macrolide resistance revealed by in vitro selection and genome analysis in Mycoplasma pneumoniae
by: Na Wang, et al.
Published: (2023-05-01)

Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study
by: Yun Li, et al.
Published: (2024-12-01)

The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: A retrospective study
by: Meng-Hsiu Yen, et al.
Published: (2023-06-01)

Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-resistant M. pneumoniae
by: Tsutomu eYamazaki, et al.
Published: (2016-05-01)